Proof of Concept Test on the efficacy of ultrasonography contrast agent perflurubutane in the differential diagnosis of nodular thyroid lesions
Phase 2
- Conditions
- odular thyroid lesions(bening and malignant)
- Registration Number
- JPRN-UMIN000020905
- Lead Sponsor
- Gunma University Hospital department of nuclear medecine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with a history of hypersensitivity to contents of perflurubutane 2.Patients who are pregnant,possibly pregnant,or nursing 3 Patients with allergies to eggs or egg products 4.Patients with pulmonary arterovenous shunts in the heart or lungs 5.Patients with severe heart or lung disease 6.Patients receiving drug therapy (such as chemotherapy) or radiotherapy for cancer,or will receive such therapy within two days of receiving contrast 7.Patients considered inappropriate for achieving the purpose this clinical study by the principal investigator or investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Contrast enhanced ultrasonography findings (will evaluate contrast enhancement patterns and vascularity patterns)
- Secondary Outcome Measures
Name Time Method 1.Evaluating contrast enhancement (will evaluate contrast enhanced sonography using three different ultrasound contrast agents). 2.Non-enhanced ultrasonography findings